MD, Chief Physician, Master's Supervisor. He is good at the differential diagnosis of benign and malignant liver tumors, interventional therapy, local therapy, targeted therapy and immunotherapy for liver cancer, as well as trans‑radial artery intervention and comprehensive treatment for refractory interventional cases.
Research Direction: Research on the regulatory mechanism of liver cancer metastasis network.
Academic Achievements: In recent years, he has published 18 SCI papers as the first or corresponding author in journals including Nature Communications (IF=12). He presides over 1 General Program of the National Natural Science Foundation of China and participates in 3 General Programs of the National Natural Science Foundation of China.
English